All Stories

  1. Therapeutic neovascularization promoted by injectable hydrogels
  2. Synthesis, characterization and application of biodegradable polymer grafted novel bioprosthetic tissue
  3. Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect
  4. PNIPAAm-co-Jeffamine ® (PNJ) scaffolds as in vitro models for niche enrichment of glioblastoma stem-like cells
  5. TMIC-22. ENRICHMENT OF GLIOBLASTOMA STEM CELLS IN PNIPAAm SCAFFOLDS
  6. PNIPAAm-based biohybrid injectable hydrogel for cardiac tissue engineering
  7. PNIPAAm-based biohybrid injectable hydrogel for cardiac tissue engineering
  8. Temperature responsive hydrogels enable transient three-dimensional tumor culturesviarapid cell recovery
  9. Bioengineered Scaffolds for 3D Analysis of Glioblastoma Proliferation and Invasion
  10. Local Gentamicin Delivery From Resorbable Viscous Hydrogels Is Therapeutically Effective
  11. Low and high voltage electroporation of in vitro human ovarian adenocarcinoma cells
  12. In vitrocharacteristics of a gelling PEGDA-QT polymer system with model drug release for cerebral aneurysm embolization
  13. Cytotoxicity,in vitromodels and preliminaryin vivostudy of dual physical and chemical gels for endovascular embolization of cerebral aneurysms
  14. In vivo embolization of lateral wall aneurysms in canines using the liquid-to-solid gelling PPODA-QT polymer system: 6-month pilot study
  15. Temperature-Responsive Graft Copolymer Hydrogels for Controlled Swelling and Drug Delivery
  16. In vitro and in vivo demonstration of physically and chemically in situ gelling NIPAAm-based copolymer system
  17. In Vivo Experimental Aneurysm Embolization in a Swine Model with a Liquid-to-Solid Gelling Polymer System: Initial Biocompatibility and Delivery Strategy Analysis
  18. In situforming, resorbable graft copolymer hydrogels providing controlled drug release
  19. Comparison of properties between NIPAAm-based simultaneously physically and chemically gelling polymer systems for use in vivo
  20. Injectable hydrogels
  21. In vitro delivery, cytotoxicity, swelling, and degradation behavior of a liquid-to-solid gelling polymer system for cerebral aneurysm embolization
  22. Surfactant-stabilized Emulsion Increases Gentamicin Elution From Bone Cement
  23. Degradation, cytotoxicity, and biocompatibility of NIPAAm-based thermosensitive, injectable, and bioresorbable polymer hydrogels
  24. Injectable biomaterials
  25. Synthesis and Characterization of Thermo-Sensitive Radio-Opaque Poly(N-Isopropylacrylamide-co-PEG-2-Iodobenzoate)
  26. Synthesis, Characterization and Properties of a Physically and Chemically Gelling Polymer System Using Poly(NIPAAm-co-HEMA-acrylate) and Poly(NIPAAm-co-cysteamine)
  27. Gelling process differences in reverse emulsion, in situ gelling polymeric materials for intracranial aneurysm embolization, formulated with injectable contrast agents
  28. Development of a Transmucosal Technique for Erythromycin Delivery to Treat Gastroparesis
  29. Bioresponsive Copolymers of Poly(N-isopropylacrylamide) with Enzyme-Dependent Lower Critical Solution Temperatures
  30. Strength of Antimicrobial Bone Cement Decreases with Increased Poragen Fraction
  31. Formulation and characterization of radio-opaque conjugatedin situgelling materials
  32. Manipulating Degradation Time in a N-isopropylacrylamide-Based Co-polymer with Hydrolysis-Dependent LCST
  33. In vivoevaluation of injectable thermosensitive polymer with time-dependent LCST
  34. Michael-Type Addition Reactions in NIPAAm-Cysteamine Copolymers Follow Second Order Rate Laws with Steric Hindrance
  35. Synthesis and characterization of radio-opaque thermosensitive poly[N-isopropylacrylamide-2,2′-(ethylenedioxy)bis(ethylamine)-2,3,5-triiodobenzamide]
  36. Hand-mixed and Premixed Antibiotic-loaded Bone Cement Have Similar Homogeneity
  37. Surfactant effects on the kinetics of Michael-type addition reaction in reverse emulsion polymeric systems
  38. Phase Behavior and Shrinking Kinetics of Thermo-Reversible Poly(N-Isopropylacrylamide-2-Hydroxyethyl Methacrylate)
  39. Controlled Release
  40. Generic Tobramycin Elutes From Bone Cement Faster Than Proprietary Tobramycin
  41. Corticosterone modulation of reproductive and immune systems trade-offs in female tree lizards: long-term corticosterone manipulations via injectable gelling material
  42. Particle Size of Fillers Affects Permeability of Polymethylmethacrylate
  43. Simultaneously Physically and Chemically Gelling Polymer System Utilizing a Poly(NIPAAm-co-cysteamine)-Based Copolymer
  44. Control of Gel Swelling and Phase Separation of Weakly Charged Thermoreversible Gels by Salt Addition
  45. New Hydrolysis-Dependent Thermosensitive Polymer for an Injectable Degradable System
  46. Islet Encapsulation: Strategies to Enhance Islet Cell Functions
  47. Islet Encapsulation: Strategies to Enhance Islet Cell Functions
  48. Poly(N-isopropylacrylamide-co-poly(ethylene glycol))-acrylate simultaneously physically and chemically gelling polymer systems
  49. Controlling delivery properties of a waterborne,in-situ-forming biomaterial
  50. In-Situ Injectable Physically and Chemically Gelling NIPAAm-Based Copolymer System for Embolization
  51. In Situ-Gelling, ErodibleN-Isopropylacrylamide Copolymers
  52. Front Cover: Macromol. Biosci. 7/2005
  53. Local Monomer Activation Model for Phase Behavior and Calorimetric Properties of LCST Gel-Forming Polymers
  54. Tubal sterilization with a waterborne polyethylene glycol in situ cross-linking material: A minimally invasive approach
  55. Mechanical Optimization of an Arteriovenous Malformation Embolization Material: A Predictive Model Analysis
  56. Gel strength and solution viscosity of temperature-sensitive, in-situ-gelling polymers for endovascular embolization
  57. Partition-controlled progesterone release from waterborne, in situ-gelling materials
  58. N-isopropylacrylamide-based Copolymers with Time-dependent LCST for a Bioresorbable Carrier
  59. Copolymers ofN-isopropylacrylamide, HEMA-lactate and acrylic acid with time-dependent lower critical solution temperature as a bioresorbable carrier
  60. Independent control of lower critical solution temperature and swelling behavior with pH for poly(N-isopropylacrylamide-co-maleic acid)
  61. Thermoreversible copolymer gels for extracellular matrix4
  62. Thermoreversible copolymer gels for extracellular matrix4
  63. Insulin release from islets of Langerhans entrapped in a poly(N-isopropylacrylamide-co-acrylic acid) polymer gel
  64. Extracellular matrix for a rechargeable cell delivery system
  65. Thermally reversible polymer gels for biohybrid artificial pancreas